Which Mechanism is Effective on the Hyperamylasaemia After Coronary Artery Bypass Surgery?

Algin H. I., Parlar A. I., YILDIZ İ., ALTUN Z. S., İŞLEKEL G. H., Uyar I., ...More

HEART LUNG AND CIRCULATION, vol.26, no.5, pp.504-508, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 5
  • Publication Date: 2017
  • Doi Number: 10.1016/j.hlc.2016.09.006
  • Journal Name: HEART LUNG AND CIRCULATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.504-508
  • Keywords: Amylase, Coronary artery bypass grafting, Cystatin C, Hyperamylasaemia, Lipase, Renal dysfunction, CARDIOPULMONARY BYPASS, CARDIAC-SURGERY, POSTOPERATIVE HYPERAMYLASEMIA, ACUTE-PANCREATITIS, RISK-FACTORS, AMYLASE, COMPLICATIONS, SERUM
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background and Aim Acute pancreatitis is one of the less frequently diagnosed lethal abdominal complications of cardiac surgery. The incidence of early postoperative period hyperamylasaemia was reported to be 30-70% of patients who underwent coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB). The mechanism of pancreatic enzyme elevation after cardiac surgery is not clear. Our aim was to determine the relationship between ischaemia associated temporary renal dysfunction and elevation of pancreatic enzymes after CABG.